Literature DB >> 32964303

Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity.

Steffi Daniel1, Marian Renwick1, Viet Q Chau1, Shyamtanu Datta1,2, Prabhavathi Maddineni3, Gulab Zode3, Emma M Wade4, Stephen P Robertson4, W Matthew Petroll1, John D Hulleman5,6.   

Abstract

Fibulin-3 (F3) is an extracellular matrix glycoprotein found in basement membranes across the body. An autosomal dominant R345W mutation in F3 causes a macular dystrophy resembling dry age-related macular degeneration (AMD), whereas genetic removal of wild-type (WT) F3 protects mice from sub-retinal pigment epithelium (RPE) deposit formation. These observations suggest that F3 is a protein which can regulate pathogenic sub-RPE deposit formation in the eye. Yet the precise role of WT F3 within the eye is still largely unknown. We found that F3 is expressed throughout the mouse eye (cornea, trabecular meshwork (TM) ring, neural retina, RPE/choroid, and optic nerve). We next performed a thorough structural and functional characterization of each of these tissues in WT and homozygous (F3-/-) knockout mice. The corneal stroma in F3-/- mice progressively thins beginning at 2 months, and the development of corneal opacity and vascularization starts at 9 months, which worsens with age. However, in all other tissues (TM, neural retina, RPE, and optic nerve), gross structural anatomy and functionality were similar across WT and F3-/- mice when evaluated using SD-OCT, histological analyses, electron microscopy, scotopic electroretinogram, optokinetic response, and axonal anterograde transport. The lack of noticeable retinal abnormalities in F3-/- mice was confirmed in a human patient with biallelic loss-of-function mutations in F3. These data suggest that (i) F3 is important for maintaining the structural integrity of the cornea, (ii) absence of F3 does not affect the structure or function of any other ocular tissue in which it is expressed, and (iii) targeted silencing of F3 in the retina and/or RPE will likely be well-tolerated, serving as a safe therapeutic strategy for reducing sub-RPE deposit formation in disease. KEY MESSAGES: • Fibulins are expressed throughout the body at varying levels. • Fibulin-3 has a tissue-specific pattern of expression within the eye. • Lack of fibulin-3 leads to structural deformities in the cornea. • The retina and RPE remain structurally and functionally healthy in the absence of fibulin-3 in both mice and humans.

Entities:  

Keywords:  Age-related macular degeneration (AMD); Cornea; EFEMP1; Fibulin-3; Malattia Leventinese (ML); Retina

Mesh:

Substances:

Year:  2020        PMID: 32964303      PMCID: PMC7606609          DOI: 10.1007/s00109-020-01974-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  64 in total

1.  Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system.

Authors:  R M Douglas; N M Alam; B D Silver; T J McGill; W W Tschetter; G T Prusky
Journal:  Vis Neurosci       Date:  2005 Sep-Oct       Impact factor: 3.241

Review 2.  Mapping wild-type and R345W fibulin-3 intracellular interactomes.

Authors:  John D Hulleman; Joseph C Genereux; Annie Nguyen
Journal:  Exp Eye Res       Date:  2016-10-21       Impact factor: 3.467

3.  Genome-wide analysis of copy number variants in age-related macular degeneration.

Authors:  Kacie J Meyer; Lea K Davis; Emily I Schindler; John S Beck; Danielle S Rudd; A Jason Grundstad; Todd E Scheetz; Terry A Braun; John H Fingert; Wallace L Alward; Young H Kwon; James C Folk; Stephen R Russell; Thomas H Wassink; Edwin M Stone; Val C Sheffield
Journal:  Hum Genet       Date:  2010-10-28       Impact factor: 4.132

4.  Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration.

Authors:  Robyn H Guymer; Robyn McNeil; Melinda Cain; Belinda Tomlin; Penelope J Allen; Chi Luu Dip; Paul N Baird
Journal:  Clin Exp Ophthalmol       Date:  2002-12       Impact factor: 4.207

Review 5.  Glaucoma.

Authors:  Harry A Quigley
Journal:  Lancet       Date:  2011-03-30       Impact factor: 79.321

6.  Corneal Fibroblast Migration Patterns During Intrastromal Wound Healing Correlate With ECM Structure and Alignment.

Authors:  W Matthew Petroll; Pouriska B Kivanany; Daniela Hagenasr; Eric K Graham
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

7.  Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.

Authors:  H Tian; J Liu; J Chen; M L Gatza; G C Blobe
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

8.  Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.

Authors:  M S Nandhu; A Kwiatkowska; V Bhaskaran; J Hayes; B Hu; M S Viapiano
Journal:  Oncogene       Date:  2017-04-17       Impact factor: 9.867

9.  Subtype-specific response of retinal ganglion cells to optic nerve crush.

Authors:  S Daniel; A F Clark; C M McDowell
Journal:  Cell Death Discov       Date:  2018-06-28

10.  CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis.

Authors:  Dong Hyun Jo; Dong Woo Song; Chang Sik Cho; Un Gi Kim; Kyu Jun Lee; Kihwang Lee; Sung Wook Park; Daesik Kim; Jin Hyoung Kim; Jin-Soo Kim; Seokjoong Kim; Jeong Hun Kim; Jung Min Lee
Journal:  Sci Adv       Date:  2019-10-30       Impact factor: 14.136

View more
  2 in total

1.  EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.

Authors:  Edward Ryan A Collantes; Manuel S Delfin; Baojian Fan; Justine May R Torregosa; Christine Siguan-Bell; Nilo Vincent de Guzman Florcruz; Jose Maria D Martinez; Barbara Joy Masna-Hidalgo; Vincent Paul T Guzman; Jewel Faith Anotado-Flores; Faye D Levina; Sophia Raine C Hernandez; Anthony A Collantes; Michael Carreon Sibulo; Shisong Rong; Janey L Wiggs
Journal:  Hum Mutat       Date:  2021-12-28       Impact factor: 4.878

2.  Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization.

Authors:  DaNae R Woodard; Emi Nakahara; John D Hulleman
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.